• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Tecnis Toric 1-Piece IOL gets FDA nod


The FDA approved Abbot’s Tecnis Toric 1-Piece IOL for the treatment of cataract with pre-existing corneal astigmatism.

Abbott Park, IL-Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Toric 1-Piece intraocular lens (IOL) for the treatment of cataract with pre-existing corneal astigmatism. Abbot will launch the product in the U.S.

According to the company, the IOL remains very stable once inserted into the eye and meets the new standard for toric IOL rotational stability as approved by the American National Standards Institute (ANSI). Tecnis Toric 1-Piece also minimizes spherical aberration for better distance vision. 

Related Videos
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Shelley Cutler, OD, FAAO, outlines her key takeaways from this year's IKA symposium
© 2024 MJH Life Sciences

All rights reserved.